Home Tags ARWR

Tag: ARWR

The Factor Everyone Ignores: Nucor Corporation (NUE), Arrowhead Pharmaceuticals, Inc. (ARWR)

Nucor Corporation (NYSE:NUE) has a price-to-sales ratio of 0.98, well above its Steel/Iron Ore competitors. For the industry, the average P/S ratio sits at...

Can These Stocks Continue To Spark? – Diamondback Energy, Inc. (FANG),...

Diamondback Energy, Inc. (NASDAQ:FANG) popped in on a high volume green day. Volume on 26-Dec-18 came in at 3.05 million contracts. The daily trading...

A Likely Value Trap For Investors: Williams-Sonoma, Inc. (WSM), Arrowhead Pharmaceuticals,...

Williams-Sonoma, Inc. (NYSE:WSM) current P/S is an impressive 0.81. The overall Home Furnishings group has an average P/S ratio of 2.8, which is significantly...

Financial Analysts Stock Recommendations: Raytheon Company (RTN), Arrowhead Pharmaceuticals, Inc. (ARWR)

Bears reigned on a brightened-volume day for Raytheon Company (NYSE:RTN) which added $0.51 between open and close. The number of shares traders wanted to...

Stocks Getting Far Too Much Hype: Arrowhead Pharmaceuticals, Inc. (ARWR), InspireMD,...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) recent decline occurred on low volume with 2.15 million contracts changing hands on 20-Dec-18. That's down from its daily average...

Financial Analysts Stock Recommendations: Arrowhead Pharmaceuticals, Inc. (ARWR), CubeSmart (CUBE)

Bears reigned on a dull-volume day for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) which lost $-0.26 between open and close. The number of shares traders wanted...

What Really Matters? – Arrowhead Pharmaceuticals, Inc. (ARWR), Washington Prime Group...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) popped in on a low volume red day. Volume on 13-Dec-18 came in at 1.76 million contracts. The daily trading...

The Factor Everyone Ignores: Monster Beverage Corporation (MNST), Arrowhead Pharmaceuticals, Inc....

Monster Beverage Corporation (NASDAQ:MNST) has a price-to-sales ratio of 8.65, well above its Beverages - Soft Drinks competitors. For the industry, the average P/S...

Here is How To Play Bottom in Arrowhead Pharmaceuticals, Inc. (ARWR),...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) recent drop took place on significantly less volume which dipped to nearly 2.11 million contracts on 07-Dec-18 versus its daily...

Blackrock Inc. is the third biggest owner of Arrowhead Pharmaceuticals, Inc....

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has made a 352.82% comeback from a 12-month low price of $3.01. It was seen 0.74% higher, changing the price...